Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 8 studies | 55% ± 18% | |
| retinal rod cell | 8 studies | 54% ± 17% | |
| retina horizontal cell | 5 studies | 24% ± 6% | |
| astrocyte | 4 studies | 27% ± 12% | |
| endothelial cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 6 studies | 39% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 2056.09 | 2590 / 2642 | 98% | 10.82 | 692 / 705 |
| ovary | 98% | 599.13 | 176 / 180 | 93% | 3.24 | 399 / 430 |
| lung | 99% | 794.26 | 571 / 578 | 88% | 4.08 | 1011 / 1155 |
| adrenal gland | 95% | 804.94 | 245 / 258 | 88% | 4.16 | 202 / 230 |
| prostate | 98% | 791.93 | 239 / 245 | 82% | 2.18 | 412 / 502 |
| kidney | 97% | 359.66 | 86 / 89 | 81% | 4.10 | 731 / 901 |
| bladder | 95% | 602.76 | 20 / 21 | 81% | 2.59 | 406 / 504 |
| uterus | 96% | 760.44 | 164 / 170 | 75% | 3.55 | 345 / 459 |
| intestine | 99% | 956.75 | 959 / 966 | 67% | 1.44 | 354 / 527 |
| esophagus | 82% | 1162.60 | 1181 / 1445 | 79% | 2.65 | 145 / 183 |
| stomach | 87% | 612.04 | 312 / 359 | 73% | 1.79 | 208 / 286 |
| breast | 69% | 241.22 | 317 / 459 | 85% | 3.48 | 947 / 1118 |
| thymus | 86% | 301.09 | 564 / 653 | 60% | 2.31 | 363 / 605 |
| pancreas | 37% | 93.88 | 120 / 328 | 98% | 4.92 | 174 / 178 |
| liver | 53% | 282.86 | 119 / 226 | 69% | 2.84 | 279 / 406 |
| skin | 61% | 174.05 | 1096 / 1809 | 44% | 1.06 | 208 / 472 |
| spleen | 99% | 448.11 | 239 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 8.10 | 27 / 29 |
| blood vessel | 88% | 331.67 | 1170 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 3.42 | 37 / 45 |
| adipose | 70% | 223.89 | 840 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 58% | 290.38 | 536 / 929 | 0% | 0 | 0 / 0 |
| heart | 33% | 95.79 | 288 / 861 | 0% | 0 | 0 / 0 |
| muscle | 6% | 10.57 | 46 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.14 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0032355 | Biological process | response to estradiol |
| GO_1990603 | Biological process | dark adaptation |
| GO_0043547 | Biological process | positive regulation of GTPase activity |
| GO_0009968 | Biological process | negative regulation of signal transduction |
| GO_1905912 | Biological process | regulation of calcium ion export across plasma membrane |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
| GO_0036367 | Biological process | light adaption |
| GO_0001975 | Biological process | response to amphetamine |
| GO_0007212 | Biological process | G protein-coupled dopamine receptor signaling pathway |
| GO_0007399 | Biological process | nervous system development |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043005 | Cellular component | neuron projection |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005096 | Molecular function | GTPase activator activity |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | RGS9 |
| Protein name | Regulator of G-protein signaling 9 RGS9 protein Regulator of G-protein signaling 9 (RGS9) |
| Synonyms | |
| Description | FUNCTION: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to GNAT1. Involved in phototransduction; key element in the recovery phase of visual transduction (By similarity). . |
| Accessions | J3QL70 ENST00000262406.10 [O75916-1] ENST00000443584.7 Q4G1B2 ENST00000635833.1 E9PD91 A0A1B0GVU3 O75916 ENST00000584234.5 Q4QRI4 ENST00000449996.7 [O75916-5] |